Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |